You are here: Industry Insights > Artemisinin

News List

Popular APIs of the Year at Pharmasources.com PharmaSources
December 10, 2024
What are the APIs that caught the highest attention in the year at PharmaSources.com？
Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives Xiaomichong
July 19, 2024
Artemisinin is a sesquiterpene lactone compound with a peroxide group structure extracted from the leaves of Artemisia annua, a plant belonging to the Asteraceae family.
Novartis reaches milestone delivery of 1 billion courses of antimalarial treatment worldpharmanews
May 20, 2021
Novartis announced that it has delivered one billion courses of antimalarial treatment since 1999. More than 90% of this artemisinin-based combination therapy (ACT) was supplied without profit to malaria-endemic countries around the globe.
ALA-artemisinin combination therapy for cancer identified europeanpharmaceuticalreview
May 06, 2019
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment…
FDA grants orphan drug designation to Artemisone by Artemis Therapeutics for malaria treatment .pharmaasia
November 16, 2017
Artemis plans to evaluate Artemisone, a synthetic artemisinin derivative with anti-viral and anti-parasitic properties, for the treatment of more diseases.
Novel combination therapy for cancer identified europeanpharmaceuticalreview
September 19, 2017
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment…
New method for producing malaria treatment at large scales europeanpharmaceuticalreview
September 11, 2017
New research demonstrates that the malaria treatment, artemisinin can now be rapidly produced by genetically engineered moss at an industrial scale…
Artemisinin has become the world’s most powerful weapon against malaria en-cphi.cn
May 12, 2017
Inherence but not obstinately following tradition; innovation but not departing from the original stand.